United Therapeutics gets FDA green light for lung perfusion device
June 29, 2026
United Therapeutics (Nasdaq:UTHR) announced today that the FDA granted premarket approval (PMA) for its LungFX perfusion device.
United Therapeutics (Nasdaq:UTHR) announced today that the FDA granted premarket approval (PMA) for its LungFX perfusion device.
Bioness Medical announced today that it received FDA 510(k) clearance for its PoNS (portable neuromodulation stimulator) system.
Michigan State University researchers have identified how ovarian cancer cells become resistant to chemotherapy and discovered a protein that, when blocked, can restore the drug’s effectiveness.
Valgen Medtech announced today that it received CE mark approval for its DragonFly transcathteter mitral repair system.
A simple bedside eye test may help predict recovery of consciousness in patients with severe brain injuries, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
Cedars-Sinai Health Sciences University investigators developed an AI-based model that can identify hospitalized patients at risk of low blood sugar up to 24 hours before the condition occurs
Researchers at the Medical University of Vienna and ETH Zurich have developed a rehabilitation platform for people suffering from the long-term effects of a stroke that combines virtual reality with targeted sensory nerve stimulation.
Associate Professor Hyun-Do Jung from Hanyang University and his team, based in Korea, have now developed an artificial intelligence (AI)-guided microneedle patch that actively changes shape at physiological temperature (37°C) to help close wounds while delivering regenerative therapy and antibacterial protection.
The clever trick that researchers at UiT The Arctic University of Norway came up with—and tested successfully—is to combine a natural polymer from algae, long chains of molecules, with a synthetic polymer. Then they added the antibiotic ciprofloxacin and folded the whole thing to pack it neatly into a capsule.
Now, new AI-aided vaccine technology developed by scientists at Cambridge University offers potential immunity against whole families of viruses and could even prevent the next pandemic, according to researchers.